芪参复康胶囊与丁螺环酮治疗焦虑症临床疗效对照研究  

QiShenFuKang Capsule and Buspirone in Antianxiety Disordes Patients with Randomized Study

作　　者：杨来启[1] 李新田[1] 高建宏[1] 林昱[1] 吴兴曲[1] 付青海[1] 范红兰 杨喜民[1] 张彦[1] 邓自合 

机构地区：[1]解放军第三医院全军精神精神疾病防治中心,陕西宝鸡721004

出　　处：《中华中医药学刊》2011年第8期1750-1751,共2页Chinese Archives of Traditional Chinese Medicine

基　　金：全军医学科学技术研究"十一五"计划专项课题(06Z012);2010年度全军中医药科研专项重点课题(10ZYX108)

摘　　要：目的:通过纯中药制剂芪参复康胶囊与丁螺环酮(buspirone,BUSPAR)治疗广泛性焦虑疗效比较,以观察芪参复康胶囊治疗焦虑症疗效。方法:117例符合CCMD-3及DSM-Ⅳ诊断标准的广泛性焦虑障碍患者,HAMA得分≥18,经6周对照观察研究,HAMARS,CGL量表及临床疗效评估。结果:芪参复康胶囊治疗广泛性焦虑症总有效率为92.06%,比丁螺环酮90.74%略高,两者无显著性差异(P>0.05)。芪参复康胶囊不良反应较丁螺环酮小而轻。结论:纯中药制剂芪参复康胶囊治疗焦虑症疗效肯定,不良反应轻,依从性好。Objective：To compare the efficacy and side efficts bitween QiShenFuKang Capsule and Buspirone.Methods：117 cases of Patients with generalizrd anxiety disorder（CCMD-3及DSM-Ⅳ） were recruited for six weeks double-blind randomized tral comparing QiShenFuKang Capsule and Buspirone.Symptom improvement and sid effect were monitored with clinical evaluation,HAMA and CGI.Results：There was no sighificant difference in the eficacy between QiShenFuKang Capsule and Buspirone.The response rat was 92.06% for QiShenFuKang Capsule and 90.74% for.Patient hwo look on QiShenFuKang Capsule reported less side and lighter efects.Conclusion： QiShenFuKang Capsule is an effectiv and well antianxiety

关 键 词：芪参复康胶囊 丁螺环酮 焦虑 

分 类 号：R285.5[医药卫生—中药学]